Gui Fu Zhang
Directeur/Bestuurslid bij New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
Profiel
Gui Fu Zhang is currently an Executive Director at China Pharmaceutical Co. Ltd., CMP Group Ltd.
(Samoa), and New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
In the past, she worked as an Executive Director at SSY Group Ltd.
from 2010 to 2012 and as an Executive Director & Finance Manager at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
from 2011 to 2013.
Actieve functies van Gui Fu Zhang
| Bedrijven | Functie | Begin |
|---|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Directeur/Bestuurslid | 23-03-2010 |
China Pharmaceutical Co. Ltd.
 China Pharmaceutical Co. Ltd. Financial ConglomeratesFinance China Pharmaceutical Co. Ltd. operates as an investment holding Chinese company. | Directeur/Bestuurslid | 09-09-2011 |
CMP Group Ltd. (Samoa)
 CMP Group Ltd. (Samoa) Financial ConglomeratesFinance Part of China Pharmaceutical Co. Ltd., CMP Group Ltd. (Samoa) operates a Samoan investment company. | Directeur/Bestuurslid | 09-09-2011 |
Eerdere bekende functies van Gui Fu Zhang
| Bedrijven | Functie | Einde |
|---|---|---|
| SSY GROUP LIMITED | Directeur/Bestuurslid | 05-04-2012 |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
CMP Group Ltd. (Samoa)
CMP Group Ltd. (Samoa) Financial ConglomeratesFinance Part of China Pharmaceutical Co. Ltd., CMP Group Ltd. (Samoa) operates a Samoan investment company. | Finance |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
China Pharmaceutical Co. Ltd.
China Pharmaceutical Co. Ltd. Financial ConglomeratesFinance China Pharmaceutical Co. Ltd. operates as an investment holding Chinese company. | Finance |